Sebastián Albertí

8.1k total citations · 1 hit paper
97 papers, 6.4k citations indexed

About

Sebastián Albertí is a scholar working on Molecular Medicine, Endocrinology and Molecular Biology. According to data from OpenAlex, Sebastián Albertí has authored 97 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Medicine, 28 papers in Endocrinology and 27 papers in Molecular Biology. Recurrent topics in Sebastián Albertí's work include Antibiotic Resistance in Bacteria (43 papers), Bacterial biofilms and quorum sensing (18 papers) and Streptococcal Infections and Treatments (17 papers). Sebastián Albertí is often cited by papers focused on Antibiotic Resistance in Bacteria (43 papers), Bacterial biofilms and quorum sensing (18 papers) and Streptococcal Infections and Treatments (17 papers). Sebastián Albertí collaborates with scholars based in Spain, United States and United Kingdom. Sebastián Albertí's co-authors include Antonio Doménech‐Sánchez, Vicente J. Benedí, Juan M. Tomás, James W. Biddle, Karen Bush, Fred C. Tenover, Hesna Yigit, Anne Marie Queenan, Luis Martínez‐Martínez and Christine D. Steward and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and The Journal of Immunology.

In The Last Decade

Sebastián Albertí

94 papers receiving 6.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Novel Carbapenem-Hydrolyzing β-Lactamase, KPC-1, from a Carbapenem-Resistant Strain ofKlebsiella pneumoniae

2001 1.3k citations Antonio Doménech‐Sánchez, Sebastián Albertí et al. Antimicrobial Agents and Chemotherapy profile →

Peers

Countries citing papers authored by Sebastián Albertí

Since Specialization

Citations

This map shows the geographic impact of Sebastián Albertí's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sebastián Albertí with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sebastián Albertí more than expected).

Fields of papers citing papers by Sebastián Albertí

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sebastián Albertí. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sebastián Albertí. The network helps show where Sebastián Albertí may publish in the future.

Co-authorship network of co-authors of Sebastián Albertí

This figure shows the co-authorship network connecting the top 25 collaborators of Sebastián Albertí. A scholar is included among the top collaborators of Sebastián Albertí based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sebastián Albertí. Sebastián Albertí is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pseudomonas aeruginosa elongation factor-Tu (EF-Tu) is an immunogenic protective protein antigen 2024 ·Vaccine ·Dina A. Moustafa, Emil Lou, (unknown), (unknown), Antonio Doménech‐Sánchez, Sebastián Albertí, Joanna B. Goldberg	3
2	Role of factor H-related protein 3 in Pseudomonas aeruginosa bloodstream infections 2024 ·Frontiers in Immunology ·(unknown), (unknown), (unknown), (unknown), Antonio Doménech‐Sánchez, Joanna B. Goldberg, Santiago Rodrı́guez de Córdoba, Sebastián Albertí	1
3	Prevalence and Control of Pseudomonas aeruginosa in Tourist Facilities across the Canary Islands, Spain 2024 ·Pathogens ·Antonio Doménech‐Sánchez, (unknown), Sebastián Albertí	0
4	Factor H-related protein 1 promotes complement-mediated opsonization of Pseudomonas aeruginosa 2024 ·Frontiers in Cellular and Infection Microbiology ·(unknown), (unknown), (unknown), (unknown), Antonio Doménech‐Sánchez, Joanna B. Goldberg, Santiago Rodrı́guez de Córdoba, Sebastián Albertí	3
5	Improvement of the Antibacterial Activity of Phage Lysin-Derived Peptide P87 through Maximization of Physicochemical Properties and Assessment of Its Therapeutic Potential 2022 ·Antibiotics ·Roberto Vázquez, Antonio Doménech‐Sánchez, (unknown), Julio Sempere, José Yuste, Sebastián Albertí, Pedro Garcı́a	7
6	Molecular Analysis of the Contribution of Alkaline Protease A and Elastase B to the Virulence of Pseudomonas aeruginosa Bloodstream Infections 2022 ·Frontiers in Cellular and Infection Microbiology ·(unknown), Laura Zamorano, (unknown), Irina Sánchez-Diener, Antonio Doménech‐Sánchez, Antonio Oliver, Sebastián Albertí	20
7	Use of Matrix-Assisted Laser Desorption Ionization Time-of-Flight Mass Spectrometry Analysis of Serum Peptidome to Classify and Predict Coronavirus Disease 2019 Severity 2021 ·Open Forum Infectious Diseases ·Rosa M. Gomila, Gabriel Martorell, Pablo A. Fraile-Ribot, Antonio Doménech‐Sánchez, (unknown), Antonio Oliver, Mercedes García‐Gasalla, Sebastián Albertí	4
8	Trimethylation of Elongation Factor-Tu by the Dual Thermoregulated Methyltransferase EftM Does Not Impact Its Canonical Function in Translation 2019 ·Scientific Reports ·Samantha M. Prezioso, Duc M. Duong, Emily G. Kuiper, Qiudong Deng, Sebastián Albertí, Graeme L. Conn, Joanna B. Goldberg	4
9	The Antimicrobials Anacardic Acid and Curcumin Are Not-Competitive Inhibitors of Gram-Positive Bacterial Pathogenic Glyceraldehyde-3-Phosphate Dehydrogenase by a Mechanism Unrelated to Human C5a Anaphylatoxin Binding 2019 ·Frontiers in Microbiology ·Sara Gómez, (unknown), (unknown), Marta Subías, (unknown), (unknown), Sebastián Albertí, Santiago Rodrı́guez de Córdoba, Francisco J. Fernández, M. Cristina Vega	11
10	Genotypic and phenotypic analyses of a Pseudomonas aeruginosa chronic bronchiectasis isolate reveal differences from cystic fibrosis and laboratory strains 2015 ·BMC Genomics ·John Varga, Mariette Barbier, Xavier Mulet, Piotr Bielecki, Jennifer Bartell, (unknown), (unknown), Lauren Hittle, Michael R. Davis, F. Heath Damron, George W. Liechti, Jacek Puchałka, Vítor A. P. Martins dos Santos, Robert K. Ernst, Jason A. Papin, Sebastián Albertí, Antonio Oliver, Joanna B. Goldberg	27
11	Lysine Trimethylation of EF-Tu Mimics Platelet-Activating Factor To Initiate Pseudomonas aeruginosa Pneumonia 2013 ·mBio ·Mariette Barbier, (unknown), (unknown), F. Heath Damron, Rosa M. Gomila, Jesús Blázquez, Joanna B. Goldberg, Sebastián Albertí	43
12	Metallo- -lactamase-producing Pseudomonas putida as a reservoir of multidrug resistance elements that can be transferred to successful Pseudomonas aeruginosa clones 2010 ·Journal of Antimicrobial Chemotherapy ·Carlos Juan, Laura Zamorano, A. Mena, Sebastián Albertí, José Luis Pérez, Antonio Oliver	87
13	Klebsiella pneumoniae AcrAB Efflux Pump Contributes to Antimicrobial Resistance and Virulence 2009 ·Antimicrobial Agents and Chemotherapy ·Emma Padilla, Enrique Llobet, Antonio Doménech‐Sánchez, Luis Martínez‐Martínez, José A. Bengoechea, Sebastián Albertí	325
14	Binding of complement regulatory proteins to Group A Streptococcus 2008 ·Vaccine ·(unknown), José María Rojo, Santiago Rodrı́guez de Córdoba, Sebastián Albertí	17
15	Novel Phosphorylcholine‐Containing Protein ofPseudomonas aeruginosaChronic Infection Isolates Interacts with Airway Epithelial Cells 2008 ·The Journal of Infectious Diseases ·Mariette Barbier, Antonio Oliver, Jayasimha Rao, Sheri L. Hanna, Joanna B. Goldberg, Sebastián Albertí	50
16	Fluticasone propionate reduces bacterial airway epithelial invasion 2008 ·European Respiratory Journal ·Mariette Barbier, Àlvar Agustí, Sebastián Albertí	29
17	Evaluation of differential gene expression in susceptible and resistant clinical isolates of Klebsiella pneumoniae by DNA microarray analysis 2006 ·Clinical Microbiology and Infection ·Antonio Doménech‐Sánchez, Vicente J. Benedí, Luis Martínez‐Martínez, Sebastián Albertí	9
18	Infecciones invasoras por estreptococos del grupo A: características clínicas y análisis microbiológico de 31 casos 2001 ·Enfermedades Infecciosas y Microbiología Clínica ·(unknown), Melchor Riera, (unknown), Antonio J. Ramírez, Sebastián Albertí, (unknown), Evelio J. Perea	5
19	Crystal structure and functional characterization of OmpK36, the osmoporin of Klebsiella pneumoniae 1999 ·Structure ·Raimund Dutzler, Gabriele Rummel, Sebastián Albertí, (unknown), (unknown), J.P. Rosenbusch, (unknown), Tilman Schirmer	127
20	Hyaluronic acid capsule modulates M protein-mediated adherence and acts as a ligand for attachment of group A Streptococcus to CD44 on human keratinocytes. 1998 ·Journal of Clinical Investigation ·Harry Schrager, Sebastián Albertí, (unknown), G J Dougherty, Michael R. Wessels	137

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact